27 employees
Invectys Therapeutics is a biopharmaceutical company focused on the development of immunotherapy approaches to treat cancer.
2010
$14M
from 1 investors over 1 rounds
Invectys raised $14M on May 20, 2020
Investors: Cancer Prevention and Research Institute of Texas